|Bid||337.97 x 1000|
|Ask||338.16 x 1100|
|Day's range||334.38 - 345.34|
|52-week range||309.43 - 463.59|
|Beta (5Y monthly)||0.90|
|PE ratio (TTM)||17.98|
|Earnings date||02 Jun 2022|
|Forward dividend & yield||0.06 (0.02%)|
|Ex-dividend date||20 Jan 2022|
|1y target est||471.00|
Cooper Companies (COO) continues to benefit from strength in its business segments.
Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -47.06% and 2.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
SAN RAMON, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 9, 2022. Al White, President and CEO, will represent the Company in a session scheduled to begin at 1:00 PM ET. This webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A webcast replay will be available approximately 48 hours after the live webcast. Ab